Healthcare Stock Insights: Arena’s Exercise Begins, Insurance Stocks Shake After SCOTUS

The biotech firm Arena Pharmaceuticals’ (NASDAQ:ARNA) appetite-suppressing anti-obesity med Belviq was recently okayed by the FDA for public sale, but the company still has plenty of work to do before the company will be driving revenues. Shares are up 1.65% in pre-market action on the first trading day of July 2012.

Don’t Miss: Here are the TOP Healthcare Sector POPS and DROPS.

It’s business as usual, i.e., falling shares, for health insurance stocks Aetna (NYSE:AET), Coventry Health Care (NYSE:CVH), UnitedHealth (NYSE:UNH), and WellPoint (NYSE:WLP), on Friday, a day after the Supreme Court decision to uphold the individual mandate for the purchase of insurance. Do investors understand the ramifications of that action, or do they suspect that the fight is far from over?

Don’t Miss: Post Bell Stock Radar: Nike, RIM and Facebook Skip HUGE RALLY.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.